WebbMar 24, 2024. This statistic shows the top therapy areas worldwide by projected spending in 2027, in billion U.S. dollars. By 2027, spending on oncology is projected to be at some … Webb1 feb. 2010 · R&D investment more than doubled over the last decade, while new molecular-entity approvals plummeted. The return on investment for a typical biopharmaceutical portfolio today often will not even cover its cost of capital. In response, industry players have embarked on a range of initiatives—in particular, externalizing …
Top therapeutic categories by number of R&D products …
WebbThe Asia-Pacific psoriasis market will be valued at $1,997.3m in 2024, growing from $933.1m in 2024, at a compound annual growth rate (CAGR) of 11.5%. Other therapeutics areas would include Dermatology, Psychotherapy, Urology and Travel Medicine. Therapy is usually decided on once the patient has been diagnosed with a specific medical … WebbTherapeutic areas: latest updates. In this section you can find the latest updates from the European Medicines Agency on cancer, cardiovascular diseases, diabetes, HIV and AIDS, … ironwood library website
Top therapeutic areas by worldwide spending 2027 forecast
Webb22 apr. 2024 · The UAE pharmaceutical market size was valued at $3.5 billion in 2024. The market is expected to grow at a CAGR of more than 7% during the forecast period. The UAE medical devices market size was valued at $2.4 billion in 2024. The market is expected to grow at a CAGR of more than 3% from 2024-2027. The United Arab Emirates (UAE) … Webb15 maj 2024 · Five things to know about Asia: Key trends shaping the market. 1. CFDA reform in full stride in China; tsunami of new-product launches expected. Recent China Food and Drug Administration (CFDA) reforms provide the basis for more optimistic fundamentals to support industry growth through the encouragement of innovation. Webb9 sep. 2024 · Furthermore, oncology therapeutics accounted for $143 billion in branded pharmaceutical sales in 2024—approximately 20 percent of global pharmaceutical sales. 2 Analyst consensus figures indicate a robust 12 percent compound annual growth rate (CAGR), and global oncology therapeutics sales are forecasted to hit $250 billion by 2024. porta phbern